行情

EXAS

EXAS

精密科学
NASDAQ

实时行情|Nasdaq Last Sale

103.40
-2.04
-1.93%
盘后: 103.40 0 0.00% 17:07 09/19 EDT
开盘
105.38
昨收
105.44
最高
106.40
最低
103.05
成交量
164.71万
成交额
--
52周最高
123.99
52周最低
53.06
市值
133.89亿
市盈率(TTM)
-58.6168
分时
5日
1月
3月
1年
5年

分析师评级

11位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

EXAS 新闻

  • Stock Investors: Do You Need a Late Cycle Plan?
  • Zacks.10小时前
  • Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work® and FORTUNE
  • PR Newswire.12小时前
  • 美国国务卿蓬佩奥谴责伊朗袭击沙特油田
  • 央视.5天前
  • 在美国腐败调查的阴影下 UAW和通用汽车接近合同期限
  • 新浪美股.5天前

更多

所属板块

生物技术和医学研究
+0.01%
制药与医学研究
+0.41%

热门股票

名称
价格
涨跌幅

EXAS 简况

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) or other scan.
展开

Webull提供EXACT Sciences Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。